OA2-3 BCL-2 antagonism decreases HIV replication and infected cell survival in acute in vitro infection.
Saved in:
Main Authors: | N. Cummins (Author), A. Sainksi (Author), S. Natesampillai (Author), S. Rizza (Author), S. Kaufmann (Author), A. Badley (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BCL-2 antagonism sensitises CTL-resistant HIV reservoirs to elimination ex vivo
by: R.B. Jones, et al.
Published: (2019) -
OA2-5 LB No evidence of ongoing replication in tissue compartments during combination antiretroviral therapy
by: G. Bozzi, et al.
Published: (2016) -
The Downregulation of MicroRNA hsa-miR-340-5p in IAV-Infected A549 Cells Suppresses Viral Replication by Targeting RIG-I and OAS2
by: Lianzhong Zhao, et al.
Published: (2019) -
OA3-2 PD-1 blockade in 12 HIV-infected patients with lung cancer
by: A. Samri, et al.
Published: (2017) -
OA08.01. Cholecystokinin antagonizes opioid function during electroacupuncture inhibitory effect on pressor reflex in rats
by: Li M, et al.
Published: (2012)